Neurology

A “real-world” analysis of millions of patient self-reported treatment records from a migraine smartphone app compares the efficacy of acute migraine medications.

In the 18-month trial, people in the early stages of Alzheimer’s who received infusions of donanemab showed 35% less decline in thinking skills compared to those given a dummy drug.

The RESTORE Network is working with a specialized group of experts on clinical trials, testing new therapies and technologies to improve the quality of life for those with neurological disorders.

From fellow parents to the doctor who helped my wife and I become parents, the doctors in my life are making it better up and down the line.

Canadian specialty pharmaceutical company Juno Pharmaceuticals has partnered with U.K.-based Rosemont Pharmaceuticals to bring more specialty liquid medicines into the country. 

It’s the first drug for an inherited form of ALS.

Two experts share their approaches

New diagnostic aid that uses the retina to diagnose schizophrenia, bipolar disorder and major depression is closer to becoming a reality.